Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma

scientific article published on 27 September 2017

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.21352
P932PMC publication ID5739622
P698PubMed publication ID29285235

P2093author name stringXue Zhang
Xiaodong Ma
Yuanshen Huang
Yabin Cheng
Liren Tang
Joshua Jiawei Zhou
P2860cites workTyrosine dephosphorylation of H2AX modulates apoptosis and survival decisionsQ24313501
The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromaroneQ28482486
Eyes absent represents a class of protein tyrosine phosphatasesQ28593158
The current status of S-100B as a biomarker in melanomaQ34246618
Aberrant expression of collagen triple helix repeat containing 1 in human solid cancersQ34538752
Current concepts of metastasis in melanoma.Q34610427
Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patientsQ35010007
Cooperative effects of INK4a and ras in melanoma susceptibility in vivoQ35195311
Chromatin structure following UV-induced DNA damage-repair or death?Q35600207
Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.Q35728896
Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.Q36356155
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisQ36691376
EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.Q37128230
ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patientsQ37352611
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.Q37737945
Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cellsQ37745812
Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.Q37777976
The immune system--a hidden treasure for biomarker discovery in cutaneous melanomaQ38040807
Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond.Q38042458
Biomarker use is associated with reduced clinical trial failure risk in metastatic melanomaQ38326094
Targeted agents and immunotherapies: optimizing outcomes in melanomaQ38856722
Key regulators of apoptosis execution as biomarker candidates in melanomaQ38866722
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanomaQ39092319
Prognostic significance of Fbw7 in human melanoma and its role in cell migrationQ39199650
Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesisQ39721556
Osteopontin expression correlates with melanoma invasion.Q40430550
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphomaQ48240295
The Drosophila eyes absent gene directs ectopic eye formation in a pathway conserved between flies and vertebrates.Q52191447
Analysis of Trends in US Melanoma Incidence and Mortality.Q53618642
Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.Q55070683
Expression of apoptosis regulators in cutaneous malignant melanomaQ77151107
Endothelin-3 is produced by metastatic melanoma cells and promotes melanoma cell survivalQ80886786
Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survivalQ83815491
Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanomaQ84159977
EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot studyQ87675280
P4510describes a project that usesImageJQ1659584
P433issue62
P407language of work or nameEnglishQ1860
P304page(s)105081-105092
P577publication date2017-09-27
P1433published inOncotargetQ1573155
P1476titleEyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma
P478volume8

Search more.